Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea
· Delayed Price · Currency is KRW 6,800.00
+30.00 (0.44%)
At close: Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
| Other Product | 34.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Growth | 2.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Peptic Ulcer Medication | 13.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Peptic Ulcer Medication Growth | -12.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diabetic Medication | 3.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diabetic Medication Growth | -7.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Goods | 3.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Goods Growth | -27.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antipyretic, Analgesic and Anti-inflammatory | 2.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antipyretic, Analgesic and Anti-inflammatory Growth | -5.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Central Nervous System Drugs | 1.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Central Nervous System Drugs Growth | -50.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| True Economy | 1.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| True Economy Growth | 125.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 229.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 31.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Mineral Preparations, Other Vitamin Preparations | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Mineral Preparations, Other Vitamin Preparations Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY undefined | FY undefined | FY undefined | FY undefined | FY undefined | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
| South Korea | 47.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -6.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 12.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -11.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|